Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
American Diabetes Association. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes - 2019. Diabetes Care. 2019 Jan;42(Suppl 1):S34-S45. doi: 10.2337/dc19-S004.
Voloshyn OI, Vasjuk VL, Voloshyna LO, Malkovych NM, Senjuk BP, Glubochenko OV, authors; Voloshyn OI, editor. Osnovy fitoterapii' i gomeopatii' [Basics of herbal medicine and homeopathy]. 2nd ed. Chernivtsi: Misto; 2017. 608 p. (in Ukrainian).
Nazarian-Samani Z, Sewell RDE, Lorigooini Z, Rafieian-Kopaei M. Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review. Curr Diab Rep. 2018 Aug 13;18(10):72. doi: 10.1007/s11892-018-1042-0.
Bashar Saad, Hilal Zaid, Siba Shanak, Slemen Kadan. Anti-diabetes and Anti-obesity Medicinal Plants and Phytochemicals: Safiety, Efficiacy, and Action Mechanisms. Cham, Switserland: Springer; 2017. 265 p. doi: 10.1007/978-3-319-54102-0.
Ning C, Wang X, Gao S, et al. Chicory inulin ameliorates type 2 diabetes mellitus and suppresses JNK and MAPK pathways in vivo and in vitro. Mol Nutr Food Res. 2017 Aug;61(8). doi: 10.1002/mnfr.201600673.
Samal L, Chaturvedi VB, Saikumar G, Somvanshi R, Pattanaik AK. Prebiotic potential of Jerusalem artichoke (Helianthus tuberosus L.) in Wistar rats: effects of levels of supplementation on hindgut fermentation, intestinal morphology, blood metabolites and immune response. J Sci Food Agric. 2015 Jun;95(8):1689-96. doi: 10.1002/jsfa.6873.
Guo J, Wang J, Song S, et al. Sphallerocarpus gracilis polysaccharide protects pancreatic β-cells via regulation of the bax/bcl-2, caspase-3, pdx-1 and insulin signalling pathways. Int J Biol Macromol. 2016 Dec;93(Pt A):829-836. doi: 10.1016/j.ijbiomac.2016.08.083.
Jin D, Zhao T, Feng WW, et al. Schisandra polysaccharide increased glucose consumption by up-regulating the expression of GLUT-4. Int J Biol Macromol. 2016 Jun;87:555-62. doi: 10.1016/j.ijbiomac.2016.03.028.
Ahn J, Um MY , Lee H, Jung CH, Heo SH, Ha TY. Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice. Evid Based Complement Alternat Med. 2013;2013:934183. doi: 10.1155/2013/934183.
Sidorova Y, Shipelin V, Mazo V, Zorin S, Petrov N, Kochetkova A. Hypoglycemic and hypolipidemic effect of Vaccinium myrtillus L. leaf and Phaseolus vulgaris L. seed coat extracts in diabetic rats. Nutrition. 2017 Sep;41:107-112. doi: 10.1016/j.nut.2017.04.010.
Karcheva-Bahchevanska DP, Lukova PK, Nikolova MM, Mladenov RD, Iliev IN. Effect of Extracts of Bilberries (Vaccinium myrtillus L.) on Amyloglucosidase and α-Glucosidase Activity. Folia Med (Plovdiv). 2017 Jun 1;59(2):197-202. doi: 10.1515/folmed-2017-0028.
Bljajić K, Petlevski R, Vujić L, et al. Chemical Composition, Antioxidant and α-Glucosidase-Inhibiting Activities of the Aqueous and Hydroethanolic Extracts of Vaccinium myrtillus Leaves. Molecules. 2017 Apr 28;22(5). pii: E703. doi: 10.3390/molecules22050703.
Luka CD, Adoga GI, Istifanus G. Phytochemical Studies of Different Fractions of Galega officinalis Extract and Their Effects on Some Biochemical Parameters in Alloxan-Induced Diabetic Rats. European Journal of Medicinal Plants. 2017;19(1):1-10. doi: 10.9734/EJMP/2017/32145.
Korsun VF, Trumpe TE, Korsun EV, Ershov NV, Ogrenich NA. Fitoterapiia protiv diabeta. Travy zhizni [Herbal medicine against diabetes. Grass of life]. Moscow: Tsentrpoligraf; 2016. 390 p. (in Russian).
Barchuk OZ, Lysiuk RM, Denys AI, Zaliska OM, Smalyuh OG, Nester MI. Experimental study of goat’s rue (Galega Officinalis L.) herb and its liquid extracts. Pharma Innovation Journal. 2017;6(11):393-397.
Kurylo KhI, Klishch IM. Comparative effect of pharmaceuticals on the basis of Galega Officinalis on the biochemical indicators in the blood of animals with type 2 experimental diabetes mellitus. Medicna i klinicna himia. 2017;19(3):35-41. doi 10.11603/mcch.2410-681X.2017.v0.i3.8200. (in Ukrainian).
Lupak MI, Khokhla MR, Hachkova GYa, et al. The alkaloid-free fraction from Galega officinalis extract prevents oxidative stress under experimental diabetes mellitus . Ukr Biochem J. 2015;87(4):78-86. doi: 10.15407/ ubj87.04.078. (in Ukrainian).
Almuaigel MF, Seif MA, Albuali HW, Alharbi O, Alhawash A. Hypoglycemic and hypolipidemic effects of aqueous extract of phaseolus vulgaris pods in streptozotocin-diabetic rats. Biomed Pharmacother. 2017 Oct;94:742-746. doi: 10.1016/j.biopha.2017.07.135.
Nuñez-Aragón PN, Segura-Campos M, Negrete-León E, et al. Protein hydrolysates and ultrafiltered < 1 KDa fractions from Phaseolus unatus, Phaseolus vulgaris and Mucuna pruriens exhibit antihyperglycemic activity, intestinal glucose absorption and α-glucosidase inhibition with no acute toxicity in rodents. J Sci Food Agric. 2019 Jan 30;99(2):587-595. doi: 10.1002/jsfa.9219.
Ulbricht C, Basch E, Cheung L, et al. An Evidence-Based Systematic Review of Elderberry and Elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl. 2014 Mar;11(1):80-120. doi: 10.3109/19390211.2013.859852.
Salvador ÂC, Król E, Lemos VC, et al. Effect of Elderberry (Sambucus nigra L.) Extract Supplementation in STZ-Induced Diabetic Rats Fed with a High-Fat Diet. Int J Mol Sci. 2016 Dec 22;18(1). pii: E13. doi: 10.3390/ijms18010013.
Shikov AN, Pozharitskaya ON, Makarov VG. Aralia elata var. mandshurica (Rupr. & Maxim.) J.Wen: An overview of pharmacological studies. Phytomedicine. 2016 Nov 15;23(12):1409-1421. doi: 10.1016/j.phymed.2016.07.011.
Kim YS, Kim M, Choi MY, et al. Aralia elata (Miq) Seem Extract Decreases O-GlcNAc Transferase Expression and Retinal Cell Death in Diabetic Mice. J Med Food. 2017 Oct;20(10):989-1001. doi: 10.1089/jmf.2016.3891.
Hwang KA, Hwang YJ, Kim GR, Choe JS. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity. BMC Complement Altern Med. 2015 Oct 5;15:347. doi: 10.1186/s12906-015-0871-5.
Seca AM, Grigore A, Pinto DC, Silva AM. The genus Inula and their metabolites: from ethnopharmacological to medicinal uses. J Ethnopharmacol. 2014 Jun 11;154(2):286-310. doi: 10.1016/j.jep.2014.04.010.
Chun J, Li RJ, Cheng MS, Kim YS. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells. Cancer Lett. 2015 Feb 1;357(1):393-403. doi: 10.1016/j.canlet.2014.11.049.
Kim M, Song K, Kim YS. Alantolactone Improves Prolonged Exposure of Interleukin-6-Induced Skeletal Muscle Inflammation Associated Glucose Intolerance and Insulin Resistance. Front Pharmacol. 2017 Jun 29;8:405. doi: 10.3389/fphar.2017.00405.
Kaur N, Kishore L, Singh R. Therapeutic effect of Linum usitatissimum L. in STZ-nicotinamide induced diabetic nephropathy via inhibition of AGE's and oxidative stress. J Food Sci Technol. 2017 Feb;54(2):408-421. doi: 10.1007/s13197-016-2477-4.
Baek HJ, Jeong YJ, Kwon JE, Ra JS, Lee SR, Kang SC. Antihyperglycemic and Antilipidemic Effects of the Ethanol Extract Mixture of Ligularia fischeri and Momordica charantia in Type 2 Diabetes-Mimicking Mice. Evid Based Complement Alternat Med. 2018 Oct 2;2018:3468040. doi: 10.1155/2018/3468040.
Shih CC, Shlau MT, Lin CH, Wu JB. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice. Phytother Res. 2014 Mar;28(3):363-71. doi: 10.1002/ptr.5003.
Efird JT, Choi YM, Davies SW, Mehra S, Anderson EJ, Katunga LA. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int J Environ Res Public Health. 2014 Feb 21;11(2):2328-45. doi: 10.3390/ijerph110202328.
Jiang B, Ji M, Liu W, Chen L, Cai Z, Zhao Y. Antidiabetic activities of a cucurbitane-type triterpenoid compound from Momordica charantia in alloxan-induced diabetic mice. Mol Med Rep. 2016 Nov;14(5):4865-4872. doi: 10.3892/mmr.2016.5800.
Shenoy RS, Prashanth KVH, Manonmani HK. In Vitro Antidiabetic Effects of Isolated Triterpene Glycoside Fraction from Gymnema sylvestre. Evid Based Complement Alternat Med. 2018 Aug 8;2018:7154702. doi: 10.1155/2018/7154702.
Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600950.
Fuller S, Stephens JM. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Adv Nutr. 2015 Mar 13;6(2):189-97. doi: 10.3945/an.114.007807.
Jiang W, Si L, Li P, et al. Serum metabonomics study on antidiabetic effects of fenugreek flavonoids in streptozotocin-induced rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:466-472. doi: 10.1016/j.jchromb.2018.06.041.
Pradeep SR, Srinivasan K. Alleviation of oxidative stress-mediated nephropathy by dietary fenugreek (Trigonella foenum-graecum) seeds and onion (Allium cepa) in streptozotocin-induced diabetic rats. Food Funct. 2018 Jan 24;9(1):134-148. doi: 10.1039/c7fo01044c.
Aziz TA, Hussain SA, Mahwi TO, Ahmed ZA. Efficacy and safety of Ginkgo biloba extract as an "add-on" treatment to metformin for patients with metabolic syndrome: a pilot clinical study. Ther Clin Risk Manag. 2018 Jul 11;14:1219-1226. doi: 10.2147/TCRM.S169503.